Analyst Ratings for Bristol-Myers Squibb Co. CVR (BMY-R)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/27/2019 | Gabelli | Kevin Kedra | New Coverage | Buy (N/A) |
N/A (3.50) |
2.13 () |
-100% | Details |
| 11/25/2019 | Mizuho » Updated 2/14/2020 |
Salim Syed | New Coverage | Outperform (N/A) |
4.52 (3.99) |
0.00 () |
0% | Details |
